We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

207 hedge funds and large institutions have $1.1B invested in Dynavax Technologies in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 64 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

33% more call options, than puts

Call options by funds: $20.8M | Put options by funds: $15.7M

16% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 64

4% more funds holding

Funds holding: 200207 (+7)

1.05% more ownership

Funds ownership: 80.35%81.4% (+1%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

19% less capital invested

Capital invested by funds: $1.36B → $1.1B (-$260M)

Holders
207
Holders Change
+7
Holders Change %
+3.5%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
74
Reduced
64
Closed
19
Calls
$20.8M
Puts
$15.7M
Net Calls
+$5.09M
Net Calls Change
+$1.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$179M +$4.01M +330,000 +2%
State Street
2
State Street
Massachusetts
$92.1M +$27.4M +2,253,376 +36%
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$91.2M
BlackRock
4
BlackRock
New York
$84.5M -$897K -73,862 -0.9%
CC
5
Chicago Capital
Illinois
$63.5M +$1.48M +121,678 +2%
Vanguard Group
6
Vanguard Group
Pennsylvania
$63.3M -$742K -61,111 -1%
PHS
7
PFM Health Sciences
California
$41.3M
Fisher Asset Management
8
Fisher Asset Management
Washington
$38.1M -$1.15M -94,614 -3%
William Blair & Company
9
William Blair & Company
Illinois
$27.7M +$3.75M +308,553 +14%
EDRH
10
Edmond de Rothschild Holding
Switzerland
$26.5M +$24.1M +1,983,700 +430%
Goldman Sachs
11
Goldman Sachs
New York
$23.6M +$4.16M +342,361 +19%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$21.6M +$913K +75,165 +4%
Bank of Montreal
13
Bank of Montreal
Ontario, Canada
$20.7M +$3.15M +259,295 +16%
Two Sigma Advisers
14
Two Sigma Advisers
New York
$18.7M +$118K +9,700 +0.6%
Millennium Management
15
Millennium Management
New York
$18.4M -$843K -69,400 -4%
RSCM
16
Rock Springs Capital Management
Maryland
$17.2M +$170K +14,000 +0.9%
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$15.2M -$8.25M -679,311 -33%
N
18
Nuveen
North Carolina
$15.2M -$500K -41,201 -3%
Two Sigma Investments
19
Two Sigma Investments
New York
$14.8M +$4.26M +350,812 +35%
Morgan Stanley
20
Morgan Stanley
New York
$13.7M -$1.98M -163,134 -11%
Northern Trust
21
Northern Trust
Illinois
$12.6M -$565K -46,547 -4%
Charles Schwab
22
Charles Schwab
California
$9.83M +$603K +49,650 +6%
Marshall Wace
23
Marshall Wace
United Kingdom
$9.39M +$175K +14,437 +2%
Norges Bank
24
Norges Bank
Norway
$8.13M
RPAM
25
Rhenman & Partners Asset Management
Sweden
$7.38M -$842K -69,324 -9%

DVAX Hedge Fund Activity: Q1 2022 in Review

207 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q1 2022, worth a combined $1.1B — down 19% from $1.36B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new DVAX positions and 19 closed out — a net gain of 8 holders — while 74 added to existing stakes and 64 trimmed.

The largest buyer was State Street, adding an estimated $27.4M. The largest seller was D.E. Shaw & Co, cutting an estimated $8.25M.

  • 207 institutional investors held Dynavax Technologies (DVAX) as of Q1 2022, up from 200 in Q4 2021.
  • Funds reported $1.1B of Dynavax Technologies stock for Q1 2022, down 19% quarter-over-quarter.
  • 27 funds opened new Dynavax Technologies positions in Q1 2022 and 19 closed out, a net change of +8 holders.
  • The largest Dynavax Technologies buyer in Q1 2022 was State Street, an estimated $27.4M added.
  • The largest Dynavax Technologies seller in Q1 2022 was D.E. Shaw & Co, an estimated $8.25M sold.

Based on aggregated 13F filings for Q1 2022.